Australian Clinical Labs Limited

ASX:ACL.AX

3.54 (AUD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 179.55179.55333.719168.634336.76168.38360.312180.156457.603228.802538.001269.001328.798164.399317.904158.952244.017115.435245.491129.85
Cost of Revenue 111.507111.507273.297109.678266.02107.635280.212115.692327.018141.988300.673131.503233.14398.121224.17995.884198.24581.962204.24492.65
Gross Profit 68.04468.04460.42258.95770.7460.74680.164.465130.58586.814237.328137.49895.65566.27893.72563.06845.77233.47341.24737.2
Gross Profit Ratio 0.3790.3790.1810.350.210.3610.2220.3580.2850.3790.4410.5110.2910.4030.2950.3970.1880.290.1680.286
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 00000000000000000000
Selling & Marketing Expenses 00000000000000000000
SG&A 42.628044.565048.571045.333047.638046.292026.721.08334.659032.5540.16237.060
Other Expenses 002.96900000000000000000
Operating Expenses 0041.59650.98748.57149.22945.33344.98547.63848.96546.29242.04526.7259.56734.65918.92532.55412.99437.0634
Operating Income 68.04468.04418.82611.71422.16914.62534.76717.38482.94740.8191.03696.19268.93534.46859.06629.53313.2186.0344.1873.2
Operating Income Ratio 0.3790.3790.0560.0690.0660.0870.0960.0960.1810.1780.3550.3580.210.210.1860.1860.0540.0520.0170.025
Total Other Income Expenses Net -53.764-53.764-11.02-7.811-6.615-53.569-2.011-1.006-12.991-5.822-6.092-3.72-63.556-62.5062.83411.1042.297-17.797-4.287-37.3
Income Before Tax 14.2814.287.8063.90315.5547.77732.75616.37869.95634.978184.94492.4725.3792.6981.27440.63735.10815.515-4.217-0.1
Income Before Tax Ratio 0.080.080.0230.0230.0460.0460.0910.0910.1530.1530.3440.3440.0160.0160.2560.2560.1440.134-0.017-0.001
Income Tax Expense 4.6964.6962.7311.3664.9942.4977.2743.63721.84210.92154.65627.3282.0631.03224.20112.101-9.4085.163-1.0170.05
Net Income 9.4919.4914.9522.47610.485.2425.42112.71148.0324.015130.21465.1073.31.6557.07328.53744.45520.678-3.2-0.05
Net Income Ratio 0.0530.0530.0150.0150.0310.0310.0710.0710.1050.1050.2420.2420.010.010.180.180.1820.179-0.013-0
EPS 0.0480.0480.0250.0120.0520.0260.130.0630.240.120.650.320.0160.010.280.20.220.102-0.0160
EPS Diluted 0.0480.0480.0250.0120.0520.0260.130.0630.240.120.650.320.0160.010.280.20.220.102-0.0160
EBITDA 22.91422.91479.81115.2484.99218.04699.93821.207133.42544.138239.3299.0465.62237.042112.832.05353.3698.9141.9386.077
EBITDA Ratio 0.1280.1280.2470.090.250.1070.2650.1180.3080.1930.4450.3680.3480.2250.320.2020.2190.0770.1710.047